Page last updated: 2024-10-24

regulation of DNA-templated transcription elongation

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides catalyzed by a DNA-dependent RNA polymerase. [GOC:mah, GOC:txnOH]

Regulation of DNA-templated transcription elongation is a complex process that ensures the accurate and efficient synthesis of RNA from a DNA template. It involves the coordinated action of various factors, including RNA polymerase, transcription factors, and chromatin remodelers.

**Initiation:**
- Transcription initiation involves the recruitment of RNA polymerase to the promoter region of a gene and the unwinding of the DNA double helix to expose the template strand.
- General transcription factors (TFs) bind to the promoter and help recruit RNA polymerase.
- Specific transcription factors can regulate gene expression by binding to enhancer or silencer elements, which can be located upstream or downstream of the gene.

**Elongation:**
- Once RNA polymerase is bound to the promoter, it begins to transcribe the DNA template, synthesizing a complementary RNA molecule.
- Elongation is the process of extending the RNA chain, adding nucleotides one at a time in a 5' to 3' direction.
- Elongation is tightly regulated to ensure accuracy and efficiency.
- RNA polymerase encounters obstacles during elongation, including nucleosomes and DNA-binding proteins.
- Several factors contribute to the regulation of elongation:
- **Elongation factors (EFs):** These proteins assist RNA polymerase in moving along the DNA template.
- **Chromatin remodelers:** These enzymes can modify chromatin structure, making the DNA more accessible to RNA polymerase.
- **Transcriptional pausing:** RNA polymerase can pause at certain points during elongation, which can be regulated by pausing factors.
- **RNA processing:** Co-transcriptional modifications, such as capping and splicing, can influence the efficiency and fate of the transcribed RNA.

**Termination:**
- Elongation continues until RNA polymerase reaches a termination signal in the DNA sequence.
- Termination signals trigger the release of the newly synthesized RNA molecule from RNA polymerase and the dissociation of RNA polymerase from the DNA template.

**Regulation of elongation:**
- Elongation can be regulated at multiple levels, including:
- **Transcription factor binding:** Specific transcription factors can modulate elongation by interacting with RNA polymerase or other elongation factors.
- **Post-translational modifications:** Modifications of transcription factors and RNA polymerase can affect their activity and ability to regulate elongation.
- **Chromatin structure:** The organization and modification of chromatin can influence the accessibility of DNA to RNA polymerase and regulate elongation.
- **RNA processing:** Co-transcriptional processing events, such as capping and splicing, can impact elongation efficiency and regulate the fate of the transcribed RNA.

**Overall, the regulation of DNA-templated transcription elongation is a complex and dynamic process that ensures the accurate and efficient synthesis of RNA. It is essential for maintaining cellular function and responding to environmental cues. The coordination of various factors, including RNA polymerase, transcription factors, and chromatin remodelers, plays a critical role in regulating this process.**'
"

Proteins (5)

ProteinDefinitionTaxonomy
DNA-directed RNA polymerase subunit betaA DNA-directed RNA polymerase subunit beta that is encoded in the genome of Escherichia coli K-12. [PRO:DNx, UniProtKB:P0A8V2]Escherichia coli K-12
DNA-directed RNA polymerase subunit beta'A DNA-directed RNA polymerase subunit beta that is encoded in the genome of Escherichia coli K-12. [PRO:DNx, UniProtKB:P0A8T7]Escherichia coli K-12
DNA-directed RNA polymerase subunit omegaA DNA-directed RNA polymerase subunit omega that is encoded in the genome of Escherichia coli K-12. [PRO:DNx, UniProtKB:P0A800]Escherichia coli K-12
DNA-directed RNA polymerase subunit alphaA DNA-directed RNA polymerase subunit alpha that is encoded in the genome of Escherichia coli K-12. [PRO:DNx, UniProtKB:P0A7Z4]Escherichia coli K-12
30S ribosomal protein S10A small ribosomal subunit protein uS10 that is encoded in the genome of Escherichia coli K-12. [PRO:DNx, UniProtKB:P0A7R5]Escherichia coli K-12

Compounds (23)

CompoundDefinitionClassesRoles
quinacrinequinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
acridines;
aromatic ether;
organochlorine compound;
tertiary amino compound
antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
chloramphenicolAmphenicol: Chloramphenicol and its derivatives.C-nitro compound;
carboxamide;
diol;
organochlorine compound
antibacterial drug;
antimicrobial agent;
Escherichia coli metabolite;
geroprotector;
Mycoplasma genitalium metabolite;
protein synthesis inhibitor
framycetinframycetin : A tetracyclic antibacterial agent derived from neomycin, being a glycoside ester of neamine and neobiosamine B.

Framycetin: A component of NEOMYCIN that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. (From Merck Index, 11th ed)
aminoglycosideallergen;
antibacterial drug;
Escherichia coli metabolite
erythromycinerythromycin : Any of several wide-spectrum macrolide antibiotics obtained from actinomycete Saccharopolyspora erythraea (formerly known as Streptomyces erythraeus).

erythromycin A : An erythromycin that consists of erythronolide A having 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively.

Erythromycin: A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
cyclic ketone;
erythromycin
neamineneamine : 2-Deoxy-D-streptamine glycosylated at the 4-oxygen with a 6-amino-alpha-D-glucosaminyl group.

neamine: fragment of NEOMYCIN B; structure in first source
2,6-dideoxy-alpha-D-glucoside;
aminoglycoside
antibacterial agent
florfenicolflorfenicol : A carboxamide that is the N-dichloroacetyl derivative of (1R,2S)-2-amino-3-fluoro-1-[4-(methanesulfonyl)phenyl]propan-1-ol. A synthetic veterinary antibiotic that is used for treatment of bovine respiratory disease and foot rot; also used in aquaculture.

florfenicol: structure given in first source
organochlorine compound;
organofluorine compound;
secondary alcohol;
secondary carboxamide;
sulfone
antimicrobial agent
antibiotic g 418antibiotic G 418: from Micromonospora rhodorangea
paromomycinparomomycin : An amino cyclitol glycoside that is the 1-O-(2-amino-2-deoxy-alpha-D-glucopyranoside) and the 3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranoside of 4,6-diamino-2,3-dihydroxycyclohexane (the 1R,2R,3S,4R,6S diastereoisomer). It is obtained from various Streptomyces species. A broad-spectrum antibiotic, it is used (generally as the sulfate salt) for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections. It is also used as a therapeutic against visceral leishmaniasis.

Paromomycin: An aminoglycoside antibacterial and antiprotozoal agent produced by species of STREPTOMYCES.
amino cyclitol glycoside;
aminoglycoside antibiotic
anthelminthic drug;
antibacterial drug;
antiparasitic agent;
antiprotozoal drug
puromycinpuromycinsantiinfective agent;
antimicrobial agent;
antineoplastic agent;
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor;
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor;
nucleoside antibiotic;
protein synthesis inhibitor
netilmicinNetilmicin: Semisynthetic 1-N-ethyl derivative of SISOMYCIN, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity.
linezolidacetamides;
morpholines;
organofluorine compound;
oxazolidinone
antibacterial drug;
protein synthesis inhibitor
zithromaxazithromycin : A macrolide antibiotic useful for the treatment of bacterial infections.

Azithromycin: A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.
macrolide antibioticantibacterial drug;
environmental contaminant;
xenobiotic
tiamulintiamulin : A carbotricyclic compound that is pleuromutilin in which the hydroxyacetate group is replaced by a 2-{[2-(diethylamino)ethyl]sulfanyl}acetate group. An antibacterial drug, tiamulin is used in veterinary medicine (generally as its hydrogen fumarate salt) for the treatment of swine dysentery caused by Serpulina hyodysenteriae.

tiamulin: 81723 HFU and tiamutin are for fumarate salt; prevents senescence in ascomycete; pleuromutilin derivative; RN given refers to ((3aS-(3aalpha,4beta,5alpha,6alpha,8beta,9alpha,9abeta,10S*))-isomer
carbotricyclic compound;
carboxylic ester;
cyclic ketone;
organic sulfide;
secondary alcohol;
semisynthetic derivative;
tertiary amino compound;
tetracyclic diterpenoid
antibacterial drug
hmr 3647
josamycinacetate ester;
aldehyde;
disaccharide derivative;
glycoside;
macrolide antibiotic;
tertiary alcohol;
tertiary amino compound
antibacterial drug;
metabolite
rifamycin svrifamycin SV : A member of the class of rifamycins that exhibits antibiotic and antitubercular properties.

rifamycin SV: RN given refers to parent cpd; structure in Merck Index, 9th ed, #8009
acetate ester;
cyclic ketal;
lactam;
macrocycle;
organic heterotetracyclic compound;
polyphenol;
rifamycins
antimicrobial agent;
antitubercular agent;
bacterial metabolite
albocyclinealbocycline: macrolide antibiotic isolated from Streptomyces bruneogriseus nov. sp. MCRL-0129; specifically anti-staphylococcal, including antibiotic-resistant strains; structuremacrolide
evernimicin
gentamicin sulfate
pristinamycin iibvirginiamycin M2: structure in first source
cem 101solithromycin: an antibacterial fluoroketolide; structure in first source
tetracyclinetetracycline : A broad-spectrum polyketide antibiotic produced by the Streptomyces genus of actinobacteria.

Tetracycline: A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis.
eravacyclineeravacycline: has antibacterial activitytetracyclines